| 000 | 01746 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514010103.0 | ||
| 264 | 0 | _c20010913 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0090-8258 | ||
| 024 | 7 |
_a10.1006/gyno.2001.6287 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlvarez, A A | |
| 245 | 0 | 0 |
_aThrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cAug 2001 |
||
| 300 |
_a273-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aEpithelial Cells _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aGenes, p53 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xmetabolism |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xblood supply |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThrombospondin 1 _xbiosynthesis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xbiosynthesis |
| 700 | 1 | _aAxelrod, J R | |
| 700 | 1 | _aWhitaker, R S | |
| 700 | 1 | _aIsner, P D | |
| 700 | 1 | _aBentley, R C | |
| 700 | 1 | _aDodge, R K | |
| 700 | 1 | _aRodriguez, G C | |
| 773 | 0 |
_tGynecologic oncology _gvol. 82 _gno. 2 _gp. 273-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/gyno.2001.6287 _zAvailable from publisher's website |
| 999 |
_c11455250 _d11455250 |
||